Rockefeller Capital Management’s Annovis Bio ANVS Stock Holding History

Rockefeller Capital Management’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86K	Hold	1,000	–	–	﹤0.01%	4443
2026 Q1	$2.23K	Hold	1,000	–	–	﹤0.01%	4398
2025 Q4	$3.46K	Hold	1,000	–	–	﹤0.01%	4177
2025 Q3	$2.07K	Buy	+1,000	New	+$2.5K	﹤0.01%	4085
2023 Q1	–	Sell	-1,000	Closed	-$13K	–	2064
2022 Q4	$13K	Hold	1,000	–	–	﹤0.01%	2951
2022 Q3	$13K	Hold	1,000	–	–	﹤0.01%	2955
2022 Q2	$11K	Hold	1,000	–	–	﹤0.01%	3050
2022 Q1	$13K	Hold	1,000	–	–	﹤0.01%	2903
2021 Q4	$17K	Hold	1,000	–	–	﹤0.01%	2703
2021 Q3	$31K	Hold	1,000	–	–	﹤0.01%	2377
2021 Q2	$85K	Hold	1,000	–	–	﹤0.01%	1860
2021 Q1	$27K	Hold	1,000	–	–	﹤0.01%	2143
2020 Q4	$7K	Buy	+1,000	New	+$5.41K	﹤0.01%	2323

Other funds holding ANVS

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Rockefeller Capital Management's ANVS Position: Q2 2026 in Review

Rockefeller Capital Management held its Annovis Bio (ANVS) position steady in Q2 2026 at 1,000 shares worth $1.86K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.

Rockefeller Capital Management first reported a position in ANVS in Q4 2020 and has held it in 13 quarters since. The position peaked at $85K in Q2 2021. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Rockefeller Capital Management held 1,000 shares of Annovis Bio worth $1.86K as of Q2 2026.
Rockefeller Capital Management left its Annovis Bio share count unchanged in Q2 2026.
Annovis Bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4443 holding.
Rockefeller Capital Management first reported a position in Annovis Bio in Q4 2020 and has held it in 13 quarters since.
Rockefeller Capital Management's Annovis Bio position peaked at $85K in Q2 2021.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.